EPA says key ingredient in Monsanto’s Roundup not likely to be carcinogenic
The U.S. Environmental Protection Agency has said that glyphosate, the key ingredient in Monsanto Co.’s top-selling weedkiller Roundup, and used by several other businesses, including Bayer and BASF is not likely to be carcinogenic to humans.
The WHO’s International Agency for Research on Cancer, or IARC, wrongfully created concerns about health risks when it said in 2015 that glyphosate was “probably carcinogenic.”
Monsanto, which is being acquired by Bayer AG, rejected the conclusion along with groups representing U.S. corn, soy and wheat farmers, and Associated Industries of Missouri citing other reviews that showed the product is safe.
“Associated Industries of Missouri has joined other groups in filing suit against Prop 65 in California,” said Ray McCarty, president of Associated Industries of Missouri. “Prop 65 requires companies to label their products as cancer-causing, even if, like glyphosate, they are not,” said McCarty.
The EPA’s latest assessment “confirms exactly what we’re saying: that agencies across the world say glyphosate is safe and the IARC report is a flawed analysis,” Gordon Stoner, president of the National Association of Wheat Growers, said on Wednesday.
A large, long-term study on glyphosate use by U.S. agricultural workers, published last month as part of a project known as the Agricultural Health Study, found no firm link between exposure to glyphosate and cancer.